Two Sigma Advisers
NCEL

Two Sigma Advisers’s NewcelX Ltd NCEL Stock Holding History

Two Sigma Advisers’s Portfolio NCEL Stock Details NCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-57
Closed -$25K – 2849
2021
Q4 		$25K Sell
57
-11
-16% -$8.42K ﹤0.01% 2536
2021
Q3 		$68K Buy
68
+41
+152% +$43.8K ﹤0.01% 2351
2021
Q2 		$34K Buy
+27
New +$36.7K ﹤0.01% 2396

Other funds holding NCEL

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Two Sigma Advisers's NCEL Position: Q1 2022 in Review

Two Sigma Advisers sold out of NewcelX Ltd (NCEL) in Q1 2022, closing a stake of 57 shares — an estimated $25K sold.

Two Sigma Advisers first reported a position in NCEL in Q2 2021 and held it in 3 quarters. The position peaked at $68K in Q3 2021. 5 funds tracked by Wall St. Rank hold NCEL as of Q1 2022.

  • Two Sigma Advisers reported no remaining NewcelX Ltd position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 57 NewcelX Ltd shares in Q1 2022, an estimated $25K.
  • Two Sigma Advisers first reported a position in NewcelX Ltd in Q2 2021 and held it in 3 quarters.
  • Two Sigma Advisers's NewcelX Ltd position peaked at $68K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held NewcelX Ltd as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.